Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Hypertension and the eye: changing perspectives

An Erratum to this article was published on 23 December 2002

Abstract

Systemic hypertension is a common condition associated with significant morbidity and mortality. Hypertension confers cardiovascular risk by causing target-organ damage that includes retinopathy in addition to heart disease, stroke, renal insufficiency and peripheral vascular disease. The recognition of hypertensive retinopathy is important in cardiovascular risk stratification of hypertensive individuals. This review reevaluates the changing perspectives in the pathophysiology, classification and prognostic significance of fundal lesions in hypertensives.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1(a–d)
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI) Arch lntern Med 1997 167: 2413–2446

  2. Hayreh SS . Systemic arterial blood pressure and the eye Duke–Elder Lecture Eye 1996 10: 5–28

    Google Scholar 

  3. Hayreh S, Servais G, Virdi P, Marcus M, Rojas P, Woolson R . Fundus lesions in malignant hypertension: III. Arterial blood pressure, biochemical and fundus changes Ophthalmology 1986 93: 45–59

    Article  CAS  PubMed  Google Scholar 

  4. Klein R . Retinopathy in a population-based study Trans Am Ophth Soc 1992 90: 561–594

    CAS  Google Scholar 

  5. Klein R, Klein B, Moss S . Blood pressure, hypertension and retinopathy in a population Trans Am Ophth Soc 1993 91: 207–222

    CAS  Google Scholar 

  6. Klein R, Klein B, Moss S, Wang Q . Hypertension and retinopathy, arteriolar narrowing and arteriovenous nicking in a population Arch Ophthalmol 1994 112: 92–98

    Article  CAS  PubMed  Google Scholar 

  7. Yu T et al. Retinopathy in older persons without diabetes and its relationship to hypertension Arch Ophthamol 1998 116: 83–89

    Article  CAS  Google Scholar 

  8. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 1998 317: 703–713

  9. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 BMJ 1998 317: 713–719

  10. Sjolie AK et al. The EURODIAB IDDM Complications Study Group. Retinopathy and vision loss in insulindependent diabetes in Europe Ophthalmology 1997 104: 252–260

    Article  CAS  PubMed  Google Scholar 

  11. Sharp PS et al. Hypertensive Retinopathy in Afro-Caribbeans and Europeans: Prevalence and Risk Factor Relationships Hypertension 1995 25: 1322–1325

    Article  CAS  PubMed  Google Scholar 

  12. Poulter NR . Independent effects of smoking on risk of hypertension: small, if present J Hypertens 2002 20: 171–172

    Article  CAS  PubMed  Google Scholar 

  13. Tuomilehto J, Elo J, Nissmen A . Smoking among patients with malignant hypertension BMJ 1982 1: 1086

    Article  Google Scholar 

  14. Isles C et al. Excess smoking in malignant-phase hypertension BMJ 1979 1: 579–581

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Bloxham CA, Beevers DG, Walker JM . Malignant hypertension and cigarette smoking BMJ 1979 1: 581–583

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Ahmed ME, Walker JM, Beevers DG, Beevers M . Lack of difference between malignant and accelerated hypertension BMJ (Clin Res Ed) 1986 25: 292(6515) 235–237

    Article  Google Scholar 

  17. Nakano Y et al. DD genotype of the angiotensin l-converting enzyme gene is a risk factor for early onset of essential hypertension in Japanese patients J Lab Clin Med 1998 131: 502–506

    Article  CAS  PubMed  Google Scholar 

  18. Pontremoli R et al. The deletion polymorphism of the angiotensin l-converting enzyme gene is associated with target organ damage in essential hypertension J Am Soc Nephrol 1996 7: 2550–2558

    Article  CAS  PubMed  Google Scholar 

  19. Yilmaz H, Isbir T, Agachan B, Aydin M . Is epsilon4 allele of apolipoprotein E associated with more severe end-organ damage in essential hypertension? Cell Biochem Funct 2001 19: 191–195

    Article  CAS  PubMed  Google Scholar 

  20. Ravera M et al. 5, 10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension Am J Hypertens 2001 14: 371–378

    Article  CAS  PubMed  Google Scholar 

  21. Hattenbach L-O et al. Absence of hypertensive retinopathy in a Turkish kindred with autosomal dominant hypertension and brachydactyly Br J Ophthalmol 1998 82: 1363–1365

    Article  Google Scholar 

  22. Roberto P et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MAGIC Study Hypertension 1997 30: 1135–1143

    Article  Google Scholar 

  23. Biesenbach G, Zazgomik J . High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy Clin Nephrol 1994 41: 211–218

    CAS  PubMed  Google Scholar 

  24. Pose Reino A et al. Relation between left ventricular hypertrophy and retinal vascular changes in mild hypertension Med Clin (Barc) 1997 108: 281–285

    CAS  Google Scholar 

  25. Shigematsu Y et al. Left ventricular geometry as an independent predictor for extracardiac target organ damage in essential hypertension Am J Hypertens 1998 11: 1171–1177

    Article  CAS  PubMed  Google Scholar 

  26. Shigematsu Y et al. Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism Hypertension 1997 29: 723–727

    Article  CAS  PubMed  Google Scholar 

  27. Uckaya G et al. Is leptin associated with hypertensive retinopathy? J Clin Endocrinol Metab 2000 85: 683–687

    CAS  PubMed  Google Scholar 

  28. Bihorac A et al. Association between salt sensitivity and target organ damage in essential hypertension Am J Hypertens 2000 13: 864–872

    Article  CAS  PubMed  Google Scholar 

  29. Heidbreder E, Huller U, Schafer B, Heidland A . Severe hypertensive retinopathy. Increased incidence in reno-parenchymal hypertension Am J Nephrol 1987 7: 394–400

    Article  CAS  PubMed  Google Scholar 

  30. Albers FJ . Clinical characteristics of atherosclerotic renovascular disease Am J Kidney Dis 1994 24: 636–641

    Article  CAS  PubMed  Google Scholar 

  31. Akpunonu BE, Mulrow PJ, Hoffman EA . Secondary hypertension: evaluation and treatment Dis Mon 1996 42: 609–722

    Article  CAS  PubMed  Google Scholar 

  32. Glodny B et al. Clinical differences between benign and malignant pheochromocytomas Endocr J 2001 48: 151–159

    Article  CAS  PubMed  Google Scholar 

  33. Cuspidi C et al. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension J Hypertens 2001 19: 2063–2070

    Article  CAS  PubMed  Google Scholar 

  34. Ibrahim YW et al. Number of perifoveal vessels in aging, hypertension and atherosclerosis: the Rotterdam Study Invest Ophthalmol Vis Sci 1998 39: 1049–1053

    CAS  PubMed  Google Scholar 

  35. Kutschbach P et al. Retinal capillary density in patients with arterial hypertension: 2-year follow-up Graefes Arch Clin Exp Ophthalmol 1998 236: 410–414

    Article  CAS  PubMed  Google Scholar 

  36. Chapman N et al. Acute effects of oxygen and carbon dioxide on retinal vascular network geometry in hypertensive and normotensive subjects Clin Sci (Lond) 2000 99: 483–488

    Article  CAS  Google Scholar 

  37. Stanton AV et al. Vascular network changes in the retina with age and hypertension J Hypertens 1995 13: 1724–1728

    Article  CAS  PubMed  Google Scholar 

  38. Haefliger IO, Meyer P, Flammer J, Luescher TF . The vascular endothelium as a regulator of the ocular circulation: new concept in ophthalmology? Surv Ophthalmol 1994 39: 123–132

    Article  CAS  PubMed  Google Scholar 

  39. Hayreh SS, Servais GE, Virdi PS . Fundus lesions in malignant hypertension. V. Hypertensive optic neuropathy Ophthalmology 1986 93: 74–87

    Article  CAS  PubMed  Google Scholar 

  40. Hayreh SS, Servais GE, Virdi PS . Fundus lesions in malignant hypertension. V. Hypertensive choroidopathy Ophthalmology 1986 93: 1383–1400

    Article  CAS  PubMed  Google Scholar 

  41. Luescher TF . The endothelium and cardiovascular disease: a complex relationship N Engl J Med 1994 330: 1081–1083

    Article  Google Scholar 

  42. Liebreich R . Ophthalmoskopischer Befund bei Morbus Brightii Albrecht von Graefes Arch Ophthalmol 1859 5: 265–268

    Article  Google Scholar 

  43. Dodson PM et al. Hypertensive retinopathy: a review of existing classification systems and a suggestion for a simplified grading system J Hum Hypertens 1996 10: 93–98

    CAS  PubMed  Google Scholar 

  44. Hayreh SS . Classification of hypertensive fundus changes and their order of appearance Ophthalmologica 1989 198: 247–260

    Article  CAS  PubMed  Google Scholar 

  45. Walsh JB . Hypertensive retinopathy: description, classification and prognosis Ophthalmology 1982 8: 1127–1131

    Article  Google Scholar 

  46. Hyman BN . The eye as a target organ: An updated classification of hypertensive retinopathy J Clin Hypertens (Greenich) 2000 2: 194–197

    Google Scholar 

  47. Pache M, Kube T, Wotf S, Kutschbach P . Do angiographic data support a detailed classification of hypertensive fundus changes? J Hum Hypertens 2002 16: 405–410

    Article  CAS  PubMed  Google Scholar 

  48. Couper DJ et al. Reliability of retinal photography in the assessment of retinal microvascular characteristics: the atherosclerosis risk in communities study Am J Ophthalmol 2002 133: 78–88

    Article  PubMed  Google Scholar 

  49. Patel V, Kohner EM . Eye in hypertension In: Swales JD (ed) Text Book of Hypertension Blackwell Scientific Publications: Oxford 1994 pp 1015–1025

    Google Scholar 

  50. Gass JDM . Stereoscopic Atlas of Macular Disease Diagnosis and Treatment Vol 1 Mosby: St Louis 1997 pp 467–476

    Google Scholar 

  51. Bock KD . Regression of retinal vascular changes by anti-hypertensive therapy Hypertension 1984 6: 158–162

    Article  Google Scholar 

  52. Talks SJ et al. The acute and long-term ocular effects of accelerated hypertension: a clinical and electrophysiological study Eye 1996 10: (Pt 3) 321–327

    Article  PubMed  Google Scholar 

  53. Hamey BA, Hart JDC, Grey RHB . Atlas of Fluorescein Angiography Wolfe: London 1994 pp 41–43

  54. Sharrett AR et al. Retinal arteriolar diameters and elevated blood pressure: the atherosclerosis risk in communities study Am J Epidemiol 1999 150: 263–270

    Article  CAS  PubMed  Google Scholar 

  55. Keith NM, Wagener HP, Barker NW . Some different types of essential hypertension: their course and prognosis Am J Med Sci 1939 197: 332–343

    Article  Google Scholar 

  56. McGregor E et al. Retinal changes in malignant hypertension BMJ 1986 282: 233–234

    Article  Google Scholar 

  57. Kishi S, Tso MOM, Hayreh SS . Fundus lesions in malignant hypertension. II. A pathologic study of experimental hypertensive optic neuropathy Arch Ophthalmol 1985 103: 1198–1206

    Article  CAS  PubMed  Google Scholar 

  58. Isles CG . Hypertensive emergencies In: Swales JD (ed) Text Book of Hypertension Blackwell Scientific Publications: Oxford 1994 pp 1233

    Google Scholar 

  59. Lip GY, Beevers M, Dodson PM, Beevers DG . Severe hypertension with lone bilateral papilloedema: a variant of malignant hypertension Blood Press 1995 4: 339–342

    Article  CAS  PubMed  Google Scholar 

  60. Hayreh SS, Jonas JB . Appearance of the optic disk and retinal nerve fiber layer in atherosclerosis and arterial hypertension: an experimental study in rhesus monkeys Am J Ophthalmol 2000 130: 91–96

    Article  CAS  PubMed  Google Scholar 

  61. MacCumber MW, Flower RW, Langham ME . lschemic hypertensive choroidopathy. Fluorescein angiography, indocyanine green videoangiography, and measurement of pulsatile blood flow Arch Ophthalmol 1993 111: 704–705

    Article  CAS  PubMed  Google Scholar 

  62. Tso MO, Jampol LM . Pathophysiology of hypertensive retinopathy Ophthalmology 1982 89: 1132–1145

    Article  CAS  PubMed  Google Scholar 

  63. Pohl ML . Siegrist's streaks in hypertensive choroidopathy J Am Optom Assoc 1988 59: 372–376

    CAS  PubMed  Google Scholar 

  64. Pierro L, Pece A, Camesasca F, Brancato R . Hypertensive choroidopathy: a case report Int Ophthalmol 1991 15: 9–14

    Article  CAS  PubMed  Google Scholar 

  65. de Venecia G, Jampol LM . The eye in accelerated hypertension. II. Localized serous detachments of the retina in patients Arch Ophthalmol 1984 102: 68–73

    Article  CAS  PubMed  Google Scholar 

  66. Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularisation and vitreous haemorrhage in branch vein occlusion: a randomised clinical trial Arch Ophthalmol 1986 104: 34–41

  67. Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion Arch Ophthalmol 1997 115: 486–491

  68. Sperduto RD et al. Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease casecontrol study Ophthalmology 1998 105: 765–771

    Article  CAS  PubMed  Google Scholar 

  69. Klein R, Klein BE, Moss SE, Meuer SM . The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study Trans Am Ophthalmol Soc 2000 98: 133–141 (discussion 141–143)

    CAS  PubMed  PubMed Central  Google Scholar 

  70. Recchia FM, Brown GC . Systemic disorders associated with retinal vascular occlusion Curr Opin Ophthalmol 2000 11: 462–467

    Article  CAS  PubMed  Google Scholar 

  71. Barbon Garcia JJ et al. Macular vein occlusion in young people Arch Soc Esp Oftalmol 2000 75: 481–484 (in Spanish)

    CAS  PubMed  Google Scholar 

  72. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P . Systemic diseases associated with various types of retinal vein occlusion Am J Ophthalmol 2001 131: 61–77

    Article  CAS  PubMed  Google Scholar 

  73. Panton RW, Goldberg MF, Farber MD . Retinal arterial macroaneurysms: risk factors and natural history Br J Ophthalmol 1990 74: 595–600

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Rabb MF, Gagliano DA, Teske MP . Retinal arterial macroaneurysms Surv Ophthalmol 1988 33: 73–96

    Article  CAS  PubMed  Google Scholar 

  75. Hayreh SS, Joos KM, Podhajsky PA, Long CR . Systemic diseases associated with non-arteritic anterior ischemic optic neuropathy Am J Ophthalmol 1994 118: 766–780

    Article  CAS  PubMed  Google Scholar 

  76. Repka MX et al. Clinical profile and long-term implications of anterior ischemic optic neuropathy Am J Ophthalmol 1983 96: 478–483

    Article  CAS  PubMed  Google Scholar 

  77. Landau K et al. 24-hour blood pressure monitoring in patients with anterior ischemic optic neuropathy Arch Ophthalmol 1996 114: 570–575

    Article  CAS  PubMed  Google Scholar 

  78. Hayreh SS, Podhajsky PA, Zimmerman B . Role of nocturnal arterial hypotension in optic nerve head ischemic disorders Ophthalmologica 1999 213: 76–96

    Article  CAS  PubMed  Google Scholar 

  79. Hayreh SS, Podhajsky PA, Zimmerman B . Non-arteritic anterior ischemic optic neuropathy—time of onset of visual loss Am J Ophthalmol 1997 124: 641–647

    Article  CAS  PubMed  Google Scholar 

  80. Hayreh SS, Podhajsky PA, Zimmerman B . Beta-blocker eye drops and nocturnal arterial hypotension Am J Ophthalmol 1999 128: 301–309

    Article  CAS  PubMed  Google Scholar 

  81. Teuscher AU, Meienberg O . Ischaemic oculomotor nerve palsy. Clinical features and vascular risk factors in 23 patients J Neurol 1985 232: 144–149

    Article  CAS  PubMed  Google Scholar 

  82. Tiffin PA, MacEwen CJ, Craig EA, Clayton G . Acquired palsy of the oculomotor, trochlear and abducens nerves Eye 1996 10: 377–384

    Article  PubMed  Google Scholar 

  83. Berlit P . Isolated and combined pareses of cranial nerves III, IV and VI. A retrospective study of 412 patients J Neurol Sci 1991 103: 10–15

    Article  CAS  PubMed  Google Scholar 

  84. Smilari P et al. Recurrent facial paralysis in a child with renovascular hypertension Pediatr Med Chir 1995 17: 461–463 (in Italian)

    CAS  PubMed  Google Scholar 

  85. Richards BW, Jones FR Jr, Younge BR . Causes and prognosis in 4,278 cases of paralysis of the oculomotor, trochlear and abducens cranial nerves Am J Ophthalmol 1992 113: 489–496

    Article  CAS  PubMed  Google Scholar 

  86. Grunwald JE et al. Diabetic glycaemic control and retinal blood flow Diabetes 1990 39: 602–607

    Article  CAS  PubMed  Google Scholar 

  87. Stratton IM et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis Diabetologia 2001 44: 156–163

    Article  CAS  PubMed  Google Scholar 

  88. JT Gillow, JM Gibson, P M Dodson . Hypertension and diabetic retinopathy—what's the story? Br J Ophthalmol 1999 83: 1083–1087

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Sleight P . The HOPE Study (Heart Outcomes Prevention Evaluation) J Renin Angiotensin Aldosterone Syst 2000 1: 18–20

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to PL Lip.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chatterjee, S., Chattopadhya, S., Hope-Ross, M. et al. Hypertension and the eye: changing perspectives. J Hum Hypertens 16, 667–675 (2002). https://doi.org/10.1038/sj.jhh.1001472

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001472

Keywords

This article is cited by

Search

Quick links